We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
-8.6%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$736M
AUM Growth
-$154M
Cap. Flow
-$53.9M
Cap. Flow %
-7.32%
Top 10 Hldgs %
22.86%
Holding
152
New
40
Increased
35
Reduced
25
Closed
52

Top Buys

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$15.2M
2
HURN icon
Huron Consulting
HURN
+$14.2M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.7M
4
AIT icon
Applied Industrial Technologies
AIT
+$13.1M
5
OLLI icon
Ollie's Bargain Outlet
OLLI
+$11.6M

Top Sells

Rank Stock Value
1
MXL icon
MaxLinear
MXL
+$18.3M
2
FRPT icon
Freshpet
FRPT
+$13.4M
3
RRR icon
Red Rock Resorts
RRR
+$12.9M
4
COHR icon
Coherent
COHR
+$12.7M
5
FORM icon
FormFactor
FORM
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 32.88%
2 Technology 23.88%
3 Industrials 20.04%
4 Consumer Staples 6.39%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOX icon
51
Box
BOX
$4.43B
$6.06M 0.82%
+241,205
New +$6.74M
CYBR
52
DELISTED
CyberArk
CYBR
$6.05M 0.82%
47,319
-14,236
-23% -$2.06M
ENPH icon
53
Enphase Energy
ENPH
$5.15B
$6.01M 0.82%
30,787
-11,265
-27% -$2.04M
DY icon
54
Dycom Industries
DY
$12.3B
$5.9M 0.8%
63,436
+12,186
+24% +$1.09M
APLS
55
DELISTED
Apellis Pharmaceuticals
APLS
$5.86M 0.8%
129,508
+79,468
+159% +$3.62M
EXTR icon
56
Extreme Networks
EXTR
$3.43B
$5.81M 0.79%
651,321
-27,099
-4% -$275K
LNTH icon
57
Lantheus
LNTH
$6.61B
$5.71M 0.77%
+86,415
New +$5.45M
FLR icon
58
Fluor
FLR
$7.04B
$5.52M 0.75%
226,682
+123,112
+119% +$3.31M
PI icon
59
Impinj
PI
$4.99B
$5.5M 0.75%
93,785
+48,220
+106% +$2.42M
NBIX icon
60
Neurocrine Biosciences
NBIX
$16.4B
$5.49M 0.75%
56,350
+14,140
+33% +$1.31M
CSL icon
61
Carlisle Companies
CSL
$15.3B
$5.46M 0.74%
+22,885
New +$5.7M
LSCC icon
62
Lattice Semiconductor
LSCC
$18.2B
$5.3M 0.72%
109,210
-600
-0.5% -$29.9K
IOVA icon
63
Iovance Biotherapeutics
IOVA
$1.94B
$5.22M 0.71%
+473,015
New +$6.2M
MANH icon
64
Manhattan Associates
MANH
$11.2B
$5.21M 0.71%
45,491
+25,031
+122% +$3.12M
AR icon
65
Antero Resources
AR
$10.6B
$5.2M 0.71%
+169,760
New +$6.21M
OPRX icon
66
OptimizeRx
OPRX
$130M
$4.95M 0.67%
180,666
+101,075
+127% +$3M
PD icon
67
PagerDuty
PD
$865M
$4.91M 0.67%
197,944
+83,154
+72% +$2.28M
MP icon
68
MP Materials
MP
$8.53B
$4.63M 0.63%
144,413
-165,282
-53% -$6.67M
FIVN icon
69
FIVE9
FIVN
$2.27B
$4.61M 0.63%
+50,550
New +$5.11M
CCXI
70
DELISTED
ChemoCentryx, Inc.
CCXI
$4.58M 0.62%
184,946
-136,623
-42% -$3.01M
MGY icon
71
Magnolia Oil & Gas
MGY
$5.62B
$4.55M 0.62%
216,625
+31,580
+17% +$789K
WMS icon
72
Advanced Drainage Systems
WMS
$11.5B
$4.14M 0.56%
45,941
-90,776
-66% -$9.33M
CROX icon
73
Crocs
CROX
$6.58B
$4.01M 0.54%
+82,405
New +$5M
BJ icon
74
BJs Wholesale Club
BJ
$12.3B
$3.97M 0.54%
+63,755
New +$4.01M
HZNP
75
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.94M 0.54%
49,397
-38,115
-44% -$3.61M
1 2
3
4 5

Similar funds

PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return

Lisanti Capital Growth's Q2 2022 Portfolio in Review

As of Q2 2022, Lisanti Capital Growth held 152 positions worth $736M, down 17% from $890M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lisanti Capital Growth withdrew a net $53.9M in Q2 2022, closing 52 positions and reducing 25 holdings. Its most notable exit was MaxLinear, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Halozyme worth $15.4M.

  • Lisanti Capital Growth's largest Q2 2022 buy was Halozyme: 350,935 shares worth $15.4M.
  • Lisanti Capital Growth added most to GitLab in Q2 2022, an estimated $10.2M increase.
  • Lisanti Capital Growth's biggest Q2 2022 reduction was Pacira BioSciences, cutting an estimated $11.2M.
  • Lisanti Capital Growth fully exited MaxLinear in Q2 2022, selling an estimated $18.3M.
  • Lisanti Capital Growth's ten largest holdings make up 23% of its $736M portfolio in Q2 2022.
  • Lisanti Capital Growth opened 40 new positions and closed 52 in Q2 2022.
  • Lisanti Capital Growth's portfolio value fell 17% quarter-over-quarter to $736M.

Based on Lisanti Capital Growth's 13F filing for Q2 2022, filed 3 Aug 2022.